Authors
- Igor Šesto — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia — ORCID: 0000-0002-2201-4425
- Krešimir Štambuk — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Hrvoje Stipic — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Tomislav Šipic — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Ante-Zvonimir Korda — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Igor Alfirevic — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Davor Richter — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Janko Szavits Nossan — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Goran Milašin — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
- Mihajlo Šesto — Magdalena Clinic for Cardiovascular Disease, Medical School, University J. J. Strossmayer in Osijek, Krapinske Toplice, Croatia
Abstract
In our hospital cardio-surgical medical council has over time developed into a genuine heart-team jointly and equally discussing the best possible treatment strategies in patients displayed. What we found interesting to see is what happened to the patients suffering from critical coronary artery disease for whom were on our cardio-surgical council further conservative treatment indicated. The study included all patients with coronary artery disease (no of patients = 85) who were in the last five years presented on our cardio-surgical council, for whom we gave up on any active revascularization strategy (percutaneous coronary intervention or coronary artery bypass graft surgery), and conservative treatment was indicated. Further more included were only patients who were not operable (coronary artery bypass graft surgery) due to anatomical and pathological constellation on their coronary arteries, and percutaneous revascularization was not possible because of extremely high risk of the procedure itself, or intervention was not technically feasible. Inclusion and exclusion criteria were as follows: significant left anterior descending artery disease, the absence of significant valvular disease, the absence of significant comorbidities that could lead to the shortening of life expectancy. Retrospective analysis of collected data, included 85 patients who were shown to our cardio-surgical council in last 5 years, we made a telephone follow-up, which found an mortality of 9.8%, 15.3% of patients were re-hospitalized because of persistent symptoms of coronary artery disease. Only 2 patients subsequently underwent surgical revascularization, none of the patients received further percutaneous revascularization. The results obtained show that in advanced coronary artery disease, which is technically not suitable for any form of revascularization, optimal medical therapy is a feasible treatment strategy. (1, 2)
Keywords
coronary artery disease, conservative treatment, inoperable
DOI
https://doi.org/10.15836/ccar.2015.240Literature
- Murphy ML, Hultgren HN, Detre K, Thomasen J, Takaro T, Participants of the Veterans Administration Cooperative Study. Treatment of chronic stable angina, a preliminary report of survival data of the randomised Veterans Administration Cooperative study. N Engl J Med. 1977;297:621–7. https://doi.org/10.1056/NEJM197709222971201
- Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for treatment of multi vessel coronary artery disease. Circulation. 2008;117(16):2079–86. https://doi.org/10.1161/CIRCULATIONAHA.107.750109